Mckesson Corp
NYSE:MCK
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
439.47
630.38
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Mckesson Corp
Wall Street
Price Targets
MCK Price Targets Summary
Mckesson Corp
According to Wall Street analysts, the average 1-year price target for
MCK
is 659.14 USD
with a low forecast of 539.54 USD and a high forecast of 750.75 USD.
MCK Last Price Targets
Mckesson Corp
The latest public price target was made on Nov 7, 2024 by
Eric Coldwell
from
Robert W. Baird
,
who expects
MCK
stock to
rise by 13%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Eric Coldwell
Robert W. Baird
|
688
USD
Upside 13% |
3 weeks ago
Nov 7, 2024
|
Baird Upgrades McKesson (MCK) to Outperform
StreetInsider
|
George Hill
Deutsche Bank
|
579
USD
Downside 5% |
2 months ago
Sep 25, 2024
|
McKesson (MCK) PT Lowered to $579 at Deutsche Bank
StreetInsider
|
|
Eric Coldwell
Robert W. Baird
|
531
USD
Downside 13% |
2 months ago
Sep 24, 2024
|
Baird Downgrades McKesson (MCK) to Neutral
StreetInsider
|
Stephen Baxter
Wells Fargo
|
535
USD
Downside 12% |
2 months ago
Sep 13, 2024
|
McKesson price target lowered to $535 from $576 at Wells Fargo
TheFly
|
|
Michael Cherny
Leerink Partners
|
665
USD
Upside 9% |
2 months ago
Sep 6, 2024
|
McKesson (MCK) PT Lowered to $665 at Leerink Partners
StreetInsider
|
Michael Cherny
Bank of America Securities
|
635
USD
Upside 4% |
2 months ago
Sep 5, 2024
|
BofA Securities Reiterates Buy Rating on McKesson (MCK) Following Sale of Rexall and Well.ca
StreetInsider
|
Ann Hynes
Mizuho Securities
|
570
USD
Downside 7% |
3 months ago
Aug 8, 2024
|
McKesson (MCK) PT Raised to $570 at Mizuho
StreetInsider
|
|
Eric Coldwell
Robert W. Baird
|
694
USD
Upside 14% |
4 months ago
Jul 9, 2024
|
McKesson price target raised to $694 from $679 at Baird
TheFly
|
David Toung
Argus Research
|
670
USD
Upside 10% |
5 months ago
Jun 24, 2024
|
McKesson (MCK) PT Raised to $670 at Argus
StreetInsider
|
|
Eric Coldwell
Robert W. Baird
|
679
USD
Upside 11% |
6 months ago
May 29, 2024
|
McKesson (MCK) PT Raised to $679 at Baird
StreetInsider
|
|
David Toung
Argus Research
|
570
USD
Downside 7% |
7 months ago
Apr 10, 2024
|
McKesson (MCK) PT Raised to $570 at Argus
StreetInsider
|
|
Eric Coldwell
Robert W. Baird
|
603
USD
Downside 1% |
7 months ago
Apr 5, 2024
|
McKesson (MCK) PT Raised to $603 at Baird
StreetInsider
|
|
Eric Coldwell
Robert W. Baird
|
567
USD
Downside 7% |
9 months ago
Feb 8, 2024
|
Medical Supplies-Focused McKesson Shares Fall On Q3 Earnings Performance, Analyst Says Street 'Wanted More'
Benzinga
|
|
David Toung
Argus Research
|
480
USD
Downside 21% |
9 months ago
Feb 7, 2024
|
McKesson Earnings Are Imminent; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Benzinga
|
Erin Wright
Morgan Stanley
|
480
USD
Downside 21% |
9 months ago
Feb 7, 2024
|
McKesson Earnings Are Imminent; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Benzinga
|
|
Ann Hynes
Mizuho Securities
|
450
USD
Downside 26% |
9 months ago
Feb 7, 2024
|
McKesson Earnings Are Imminent; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Benzinga
|
|
Unknown Analyst
Morgan Stanley
|
426
USD
Downside 30% |
1 year ago
Feb 2, 2023
|
Morgan Stanley Maintains Overweight on McKesson, Raises Price Target to $426
Benzinga
|
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is MCK's stock price target?
Price Target
659.14
USD
According to Wall Street analysts, the average 1-year price target for
MCK
is 659.14 USD
with a low forecast of 539.54 USD and a high forecast of 750.75 USD.
What is Mckesson Corp's Revenue forecast?
Projected CAGR
11%
For the last 8 years the
compound annual growth rate for
Mckesson Corp's revenue is
6%.
The projected
CAGR
for the next 3 years is
11%.
What is Mckesson Corp's Operating Income forecast?
Projected CAGR
18%
For the last 8 years the
compound annual growth rate for
Mckesson Corp's operating income is
1%.
The projected
CAGR
for the next 3 years is
18%.
What is Mckesson Corp's Net Income forecast?
Projected CAGR
21%
For the last 8 years the
compound annual growth rate for
Mckesson Corp's net income is
4%.
The projected
CAGR
for the next 3 years is
21%.
You don't have any saved screeners yet
